• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝肾功能酪氨酸血症:简化饮食对代谢控制和临床结局的影响。

Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome.

机构信息

Department of Paediatrics, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany.

Universitätsklinikum Düsseldorf, Klinik für Allgemeine Pädiatrie, Moorenstraße 5, 40225 Düsseldorf, Germany.

出版信息

Nutrients. 2020 Dec 31;13(1):134. doi: 10.3390/nu13010134.

DOI:10.3390/nu13010134
PMID:33396520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7824011/
Abstract

: Tyrosinaemia type 1 is a rare inherited metabolic disease caused by an enzyme defect in the tyrosine degradation pathway. It is treated using nitisinone and a low-protein diet. In a workshop in 2013, a group of nutritional specialists from Germany, Switzerland and Austria agreed to advocate a simplified low-protein diet and to allow more natural protein intake in patients with tyrosinaemia type 1. This retrospective study evaluates the recommendations made at different treatment centers and their impact on clinical symptoms and metabolic control. : For this multicenter study, questionnaires were sent to nine participating treatment centers to collect data on the general therapeutic approach and data of 47 individual patients treated by those centers. : Dietary simplification allocating food to 3 categories led to increased tyrosine and phenylalanine blood concentrations without weighing food. Phenylalanine levels were significantly higher in comparison to a strict dietary regimen whereas tyrosine levels in plasma did not change. Non-inferiority was shown for the simplification and liberalization of the diet. Compliance with dietary recommendations was higher using the simplified diet in comparison to the stricter approach. Age correlates negatively with compliance. : Simplification of the diet with increased natural protein intake based on three categories of food may be implemented in the diet of patients with tyrosinaemia type 1 without significantly altering metabolic control. Patient compliance is strongly influencing tyrosine blood concentrations. A subsequent prospective study with a larger sample size is necessary to get a better insight into the effect of dietary recommendations on metabolic control.

摘要

酪氨酸血症 1 型是一种罕见的遗传性代谢疾病,由酪氨酸降解途径中的酶缺陷引起。它采用尼替西农和低蛋白饮食进行治疗。在 2013 年的一次研讨会上,来自德国、瑞士和奥地利的一组营养专家一致主张简化低蛋白饮食,并允许酪氨酸血症 1 型患者摄入更多天然蛋白质。本回顾性研究评估了在不同治疗中心提出的建议及其对临床症状和代谢控制的影响。

在这项多中心研究中,向 9 个参与治疗中心发送了问卷,以收集有关一般治疗方法的数据和这些中心治疗的 47 名个体患者的数据。

饮食简化将食物分为 3 类,导致酪氨酸和苯丙氨酸血液浓度升高,而无需称重食物。与严格的饮食方案相比,苯丙氨酸水平显著升高,而血浆中的酪氨酸水平没有变化。饮食简化和放宽显示出非劣效性。与更严格的方法相比,简化饮食的饮食建议遵守率更高。年龄与依从性呈负相关。

基于 3 类食物增加天然蛋白质摄入的饮食简化可以在酪氨酸血症 1 型患者的饮食中实施,而不会显著改变代谢控制。患者的依从性强烈影响酪氨酸的血液浓度。需要进行后续的前瞻性研究,以获得更大的样本量,从而更好地了解饮食建议对代谢控制的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/7824011/b23e551b2b3b/nutrients-13-00134-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/7824011/62505992856e/nutrients-13-00134-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/7824011/7c67520631f3/nutrients-13-00134-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/7824011/7cddff56d1b6/nutrients-13-00134-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/7824011/3bc9e2c12fab/nutrients-13-00134-g0A4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/7824011/b23e551b2b3b/nutrients-13-00134-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/7824011/62505992856e/nutrients-13-00134-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/7824011/7c67520631f3/nutrients-13-00134-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/7824011/7cddff56d1b6/nutrients-13-00134-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/7824011/3bc9e2c12fab/nutrients-13-00134-g0A4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/7824011/b23e551b2b3b/nutrients-13-00134-g001a.jpg

相似文献

1
Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome.肝肾功能酪氨酸血症:简化饮食对代谢控制和临床结局的影响。
Nutrients. 2020 Dec 31;13(1):134. doi: 10.3390/nu13010134.
2
Natural Protein Tolerance and Metabolic Control in Patients with Hereditary Tyrosinaemia Type 1.遗传性酪氨酸血症 1 型患者的天然蛋白质耐受性和代谢控制。
Nutrients. 2020 Apr 19;12(4):1148. doi: 10.3390/nu12041148.
3
Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice.168例肝肾型酪氨酸血症患者的横断面研究及其对临床实践的意义。
Orphanet J Rare Dis. 2014 Aug 1;9:107. doi: 10.1186/s13023-014-0107-7.
4
Long-term safety and outcomes in hereditary tyrosinaemia type 1 with nitisinone treatment: a 15-year non-interventional, multicentre study.尼替西农治疗遗传性酪氨酸血症 1 型的 15 年非干预性、多中心研究:长期安全性和结局。
Lancet Diabetes Endocrinol. 2021 Jul;9(7):427-435. doi: 10.1016/S2213-8587(21)00092-9. Epub 2021 May 21.
5
Diurnal variation of phenylalanine concentrations in tyrosinaemia type 1: should we be concerned?1 型酪氨酸血症中苯丙氨酸浓度的昼夜变化:我们是否应该关注?
J Hum Nutr Diet. 2012 Apr;25(2):111-6. doi: 10.1111/j.1365-277X.2011.01215.x. Epub 2011 Dec 15.
6
Clinical utilization of dried blood spot nitisinone (NTBC) and succinylacetone (SA) concentrations in hereditary tyrosinaemia type 1 - A UK centre experience.1型遗传性酪氨酸血症中干血斑中尼替西农(NTBC)和琥珀酰丙酮(SA)浓度的临床应用——英国一家中心的经验
Ann Clin Biochem. 2020 Nov;57(6):412-419. doi: 10.1177/0004563220961760. Epub 2020 Sep 30.
7
Corneal depositions in tyrosinaemia type I during treatment with Nitisinone.在使用尼替西农治疗期间,I型酪氨酸血症患者的角膜沉积物。
BMJ Case Rep. 2012 Nov 30;2012:bcr2012006301. doi: 10.1136/bcr-2012-006301.
8
Predicting tyrosinaemia: a mathematical model of 4-hydroxyphenylpyruvate dioxygenase inhibition by nitisinone in rats.预测酪氨酸血症:尼替西农对大鼠4-羟基苯丙酮酸双加氧酶抑制作用的数学模型
Math Med Biol. 2017 Sep 1;34(3):335-390. doi: 10.1093/imammb/dqw006.
9
Emotional and behavioural functioning in children with tyrosinaemia type 1.1 型酪氨酸血症患儿的情绪和行为功能。
Pediatr Endocrinol Diabetes Metab. 2024;30(1):8-13. doi: 10.5114/pedm.2024.138666.
10
Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I.酪蛋白糖巨肽:I型酪氨酸血症中的一种替代蛋白质替代品。
Nutrients. 2021 Sep 16;13(9):3224. doi: 10.3390/nu13093224.

引用本文的文献

1
Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1: Consensus group recommendations from the German-speaking countries.1型酪氨酸血症患者的诊断、治疗、管理及监测:德语国家共识小组建议
J Inherit Metab Dis. 2025 Jan;48(1):e12824. doi: 10.1002/jimd.12824.
2
Determination of the Protein and Amino Acid Content of Fruit, Vegetables and Starchy Roots for Use in Inherited Metabolic Disorders.测定水果、蔬菜和淀粉根茎中的蛋白质和氨基酸含量,用于遗传性代谢疾病。
Nutrients. 2024 Aug 23;16(17):2812. doi: 10.3390/nu16172812.
3
UK Dietary Practices for Tyrosinaemias: Time for Change.

本文引用的文献

1
Natural Protein Tolerance and Metabolic Control in Patients with Hereditary Tyrosinaemia Type 1.遗传性酪氨酸血症 1 型患者的天然蛋白质耐受性和代谢控制。
Nutrients. 2020 Apr 19;12(4):1148. doi: 10.3390/nu12041148.
2
Daily variation of NTBC and its relation to succinylacetone in tyrosinemia type 1 patients comparing a single dose to two doses a day.1 型酪氨酸血症患者每日测定 NTBG 及其与丁二酮的变化,比较每日单剂量与双剂量。
J Inherit Metab Dis. 2018 Mar;41(2):181-186. doi: 10.1007/s10545-017-0112-9. Epub 2017 Nov 23.
3
Presumptive brain influx of large neutral amino acids and the effect of phenylalanine supplementation in patients with Tyrosinemia type 1.
英国酪氨酸血症患者的饮食实践:是时候改变了。
Nutrients. 2022 Dec 7;14(24):5202. doi: 10.3390/nu14245202.
4
Hereditary tyrosinemia type Ⅰ: newborn screening, diagnosis and treatment.遗传性酪氨酸血症 I 型:新生儿筛查、诊断和治疗。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021 Aug 25;50(4):514-523. doi: 10.3724/zdxbyxb-2021-0255.
5
Physical Growth of Patients with Hereditary Tyrosinaemia Type I: A Single-Centre Retrospective Study.I 型遗传性酪氨酸血症患者的体格生长:单中心回顾性研究。
Nutrients. 2021 Aug 31;13(9):3070. doi: 10.3390/nu13093070.
1型酪氨酸血症患者大脑对大中性氨基酸的推测性摄取及苯丙氨酸补充的影响
PLoS One. 2017 Sep 26;12(9):e0185342. doi: 10.1371/journal.pone.0185342. eCollection 2017.
4
Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations.I 型酪氨酸血症的诊断和治疗:美国和加拿大共识小组的回顾和建议。
Genet Med. 2017 Dec;19(12). doi: 10.1038/gim.2017.101. Epub 2017 Aug 3.
5
Biochemical and Clinical Aspects of Hereditary Tyrosinemia Type 1.1型遗传性酪氨酸血症的生化与临床方面
Adv Exp Med Biol. 2017;959:9-21. doi: 10.1007/978-3-319-55780-9_2.
6
Long-term cognitive functioning in individuals with tyrosinemia type 1 treated with nitisinone and protein-restricted diet.接受尼替西农和蛋白质限制饮食治疗的1型酪氨酸血症患者的长期认知功能
Mol Genet Metab Rep. 2017 Mar 26;11:12-16. doi: 10.1016/j.ymgmr.2017.01.016. eCollection 2017 Jun.
7
Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls.与健康对照相比,1型酪氨酸血症患者的神经认知结局。
Orphanet J Rare Dis. 2016 Jun 29;11(1):87. doi: 10.1186/s13023-016-0472-5.
8
Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice.168例肝肾型酪氨酸血症患者的横断面研究及其对临床实践的意义。
Orphanet J Rare Dis. 2014 Aug 1;9:107. doi: 10.1186/s13023-014-0107-7.
9
Impaired cognitive functioning in patients with tyrosinemia type I receiving nitisinone.Ⅰ型酪氨酸血症患者接受尼替西农治疗后认知功能受损。
J Pediatr. 2014 Feb;164(2):398-401. doi: 10.1016/j.jpeds.2013.10.001. Epub 2013 Nov 14.
10
Recommendations for the management of tyrosinaemia type 1.推荐 1 型酪氨酸血症的管理。
Orphanet J Rare Dis. 2013 Jan 11;8:8. doi: 10.1186/1750-1172-8-8.